Aurobindo Pharma gets USFDA nod for generic cancer drug Bortezomib
“Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma (cancer of plasma cells) and is also used to treat adult...
Continue ReadingJulphar to launch over 100 new medicines as part of growth strategy
DUBAI: Gulf Pharmaceutical Industries Julphar has announced its Strategy 2030, an effort to drive transformation that will contribute to higher shareholder returns.According to the Emirates...
Continue ReadingWHO ‘strongly recommends’ Pfizer’s Covid pill
For the same patients, the WHO also made a “conditional (weak) recommendation” of the antiviral drug remdesivir made by US biotech firm Gilead — which...
Continue ReadingNutraceutical manufacturing, the complex process simplified through vertical integration.
According to the October 2021 report by the US-based Grand View Research, the global nutraceutical market is projected to reach $8,26,426.3 million by 2028, expanding...
Continue ReadingEmbracing Digitisation in Pharma Adopting the New Normal
The summit will analyze how the new-age technologies — Artificial Intelligence (AI), Internet of Things (IoT), robotics, 3D printing, and blockchain are transforming the pharma...
Continue ReadingKiran Mazumdar-Shaw awarded with the prestigious Bharat Asmita National Award 2021
She was entitled as Bharat Asmita Vigyaan – Tantragyaan Shreshtha at the 17th Bharat Asmita National Award. Kiran Mazumdar-Shaw, Executive Chairman and Managing Director of...
Continue ReadingTeva CEO: We’re in talks to co-produce Covid-19 vaccine
Kare Schultz told “Bloomberg” that the Israeli pharmaceutical company has offered its manufacturing capacity to help with vaccine production. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...
Continue ReadingRhizen”s cancer drug Umbralisib gets USFDA nod: Alembic Pharma
Drug firm Alembic Pharma said its associate company Rhizen Pharmaceuticals AG”s novel drug Umbralisib has received accelerated approval from the US health regulator for treatment...
Continue Reading18th BIO-ASIA ON 22-02-21 & 23-02-21
Asia’s largest life-sciences and healthcare forum BioAsia, in its 18th edition, will focus on Covid-19, Global Health, Pharma and MedTech. To be held on 22nd...
Continue Reading